EMvision Medical Devices Ltd
ASX:EMV
Intrinsic Value
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. [ Read More ]
The intrinsic value of one
EMV
stock under the Base Case scenario is
0.32
AUD.
Compared to the current market price of 2.1 AUD,
EMvision Medical Devices Ltd
is
Overvalued by 85%.
EMV's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
EMV or that its price is influenced by factors unrelated to fundamentals.
EMvision Medical Devices Ltd's market capitalization is 163.7m AUD.
EMV stock price is 2.1 AUD.
EMV stock (0.32 AUD) is 85% less than its price (2.1 AUD).
EMV. Open DCF Valuation
EMV stock (0.32 AUD) is 85% less than its price (2.1 AUD). Open Relative Valuation
EMV has upside potential of 10% compared to the average analyst price target.
Open Wall St Estimates
EMV's ROE (Return on Equity) has increased in the last 3 years from -49% to -48%, and is approaching profitability.
EMV's Revenue has grown by an exceptional 50% over the past 12 months.
EMV's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -2 037% to -247%, and is approaching profitability.
EMV's short-term assets (10m AUD) exceed its short-term liabilties (5m AUD).
EMV's long-term assets (11m AUD) exceed its long-term liabilties (6m AUD).
EMV has negative Operating Income for the last twelve months.
EMV has negative Net Income for the last twelve months.
EMV's ROE (Return on Equity) for the past 12 months is negative and is equal to -48%.
EMV's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -247%.
EMV's D/E (Debt to Equity) is very low and is equal to 0.48.
EMV has negative Free Cash Flow for the last twelve months.
EMV's Revenue has been growing by an exceptional 114% per year for the last 3 years.
EMV has negative Net Debt. This means that the company has more cash and short-term investments (8m AUD) than debt (3m AUD).
EMV has negative three-year average ROE (Return on Equity): -65%. The company is not efficient at transforming stockholders' equity into net income.
EMV has negative three-year average ROIC (Return on Invested Capital): -1 329%. The company is not efficient at using invested capital to generate operating income.
EMV's Altman Z-Score is very high and is equal to 11.66.
EMV earns more than enough operating income (-3m AUD) to safely cover interest payments on its debt (-12k AUD).
Valuation Backtest
EMvision Medical Devices Ltd
Run backtest to discover the historical profit from buying and selling
EMV
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
EMvision Medical Devices Ltd
Balance Sheet Decomposition
EMvision Medical Devices Ltd
| Current Assets | 10.1m |
| Cash & Short-Term Investments | 8.5m |
| Receivables | 1.4m |
| Other Current Assets | 237.7k |
| Non-Current Assets | 1.1m |
| PP&E | 643.9k |
| Intangibles | 480k |
| Current Liabilities | 5.3m |
| Accounts Payable | 819.7k |
| Accrued Liabilities | 341.8k |
| Short-Term Debt | 2.5m |
| Other Current Liabilities | 1.6m |
| Non-Current Liabilities | 246.5k |
| Long-Term Debt | 191.2k |
| Other Non-Current Liabilities | 55.3k |
Earnings Waterfall
EMvision Medical Devices Ltd
|
Revenue
|
8.9m
AUD
|
|
Operating Expenses
|
-11.5m
AUD
|
|
Operating Income
|
-2.7m
AUD
|
|
Other Expenses
|
-540.5k
AUD
|
|
Net Income
|
-3.2m
AUD
|
Free Cash Flow Analysis
EMvision Medical Devices Ltd
EMV Profitability Score
Profitability Due Diligence
EMvision Medical Devices Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
EMvision Medical Devices Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
EMV Solvency Score
Solvency Due Diligence
EMvision Medical Devices Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
EMvision Medical Devices Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EMV Price Targets Summary
EMvision Medical Devices Ltd
According to Wall Street analysts, the average 1-year price target for
EMV
is 2.3 AUD
.
Shareholder Return
EMV Price
EMvision Medical Devices Ltd
| Average Annual Return | 86.88% |
| Standard Deviation of Annual Returns | 166.54% |
| Max Drawdown | -73% |
| Market Capitalization | 163.7m AUD |
| Shares Outstanding | 85 424 900 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
EMvision Medical Devices Ltd
Country
Industry
Market Cap
Dividend Yield
Description
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.
Contact
IPO
Employees
Officers
The intrinsic value of one
EMV
stock under the Base Case scenario is
0.32
AUD.
Compared to the current market price of 2.1 AUD,
EMvision Medical Devices Ltd
is
Overvalued by 85%.
You don't have any saved screeners yet
